The stock of Clover Health Investments Corp (NASDAQ:CLOV) last traded at $0.82, down -4.95% from the previous session.
CLOV stock price is now -10.33% away from the 50-day moving average and -19.87% away from the 200-day moving average. The market capitalization of the company currently stands at $405.27M.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp (NASDAQ: CLOV). On February 02, 2022, Canaccord Genuity recently initiated its ‘Buy’ rating on the stock quoting a target price of $6, while ‘SVB Leerink’ rates the stock as ‘Mkt Perform’
In other news, Loengard Anna U, Director bought 137,000 shares of the company’s stock on Mar 14 ’24. The stock was bought for $100,010 at an average price of $0.73. Upon completion of the transaction, the Director now directly owns 538,841 shares in the company, valued at $0.44 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 14 ’24, Director Loengard Anna U bought 13,625 shares of the business’s stock. A total of $9,946 was incurred on buying the stock at an average price of $0.73. This leaves the insider owning 15,125 shares of the company worth $12402.5. A total of 24.03% of the company’s stock is owned by insiders.
During the past 12 months, Clover Health Investments Corp has had a low of $0.71 and a high of $1.63. The fifty day moving average price for CLOV is $0.9130 and a two-hundred day moving average price translates $1.0238 for the stock.
The latest earnings results from Clover Health Investments Corp (NASDAQ: CLOV) was released for Dec, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.14, inline with analysts’ expectations of -$0.14. This compares to -$0.18 EPS in the same period last year. The net profit margin was -10.52% and return on equity was -67.29% for CLOV. The company reported revenue of $510.25 million for the quarter, compared to $898.79 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -43.23 percent. For the current quarter, analysts expect CLOV to generate $321.23M in revenue.
